These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 38479094)

  • 1. CRISPR-Cas based diagnostic tools: Bringing diagnosis out of labs.
    Chhipa AS; Radadiya E; Patel S
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116252. PubMed ID: 38479094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation pathogen diagnosis with CRISPR/Cas-based detection methods.
    Wang X; Shang X; Huang X
    Emerg Microbes Infect; 2020 Dec; 9(1):1682-1691. PubMed ID: 32643563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic efficiency of RT-LAMP integrated CRISPR-Cas technique for COVID-19: A systematic review and meta-analysis.
    Bhatt A; Bumbrah GS; Ruwali M; Hameed S; Fatima Z
    Pathog Glob Health; 2022 Oct; 116(7):410-420. PubMed ID: 35142264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas-mediated diagnostics.
    Li L; Shen G; Wu M; Jiang J; Xia Q; Lin P
    Trends Biotechnol; 2022 Nov; 40(11):1326-1345. PubMed ID: 35595574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-based systems for sensitive and rapid on-site COVID-19 diagnostics.
    Soh JH; Balleza E; Abdul Rahim MN; Chan HM; Mohd Ali S; Chuah JKC; Edris S; Atef A; Bahieldin A; Ying JY; Sabir JSM
    Trends Biotechnol; 2022 Nov; 40(11):1346-1360. PubMed ID: 35871983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas systems for diagnosing infectious diseases.
    Kostyusheva A; Brezgin S; Babin Y; Vasilyeva I; Glebe D; Kostyushev D; Chulanov V
    Methods; 2022 Jul; 203():431-446. PubMed ID: 33839288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas system and its use in the diagnosis of infectious diseases.
    Padmanaban V; Ranganathan UDK
    Microbiol Res; 2022 Oct; 263():127100. PubMed ID: 35849921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SHERLOCK and DETECTR: CRISPR-Cas Systems as Potential Rapid Diagnostic Tools for Emerging Infectious Diseases.
    Mustafa MI; Makhawi AM
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33148705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
    Aman R; Mahas A; Mahfouz M
    ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Novel COVID-19 nsp8 One-Tube RT-LAMP-CRISPR Assay for SARS-CoV-2 Diagnosis.
    Yip CC; Sridhar S; Chan WM; Ip JD; Chu AW; Leung KH; Cheng VC; Yuen KY; To KK
    Microbiol Spectr; 2022 Dec; 10(6):e0196222. PubMed ID: 36445095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas12a combined with reverse transcription recombinase polymerase amplification for sensitive and specific detection of human norovirus genotype GII.4.
    Qian W; Huang J; Wang X; Wang T; Li Y
    Virology; 2021 Dec; 564():26-32. PubMed ID: 34601182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases.
    Lou J; Wang B; Li J; Ni P; Jin Y; Chen S; Xi Y; Zhang R; Duan G
    Mol Biol Rep; 2022 Dec; 49(12):11301-11311. PubMed ID: 35857175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
    Ali Z; Aman R; Mahas A; Rao GS; Tehseen M; Marsic T; Salunke R; Subudhi AK; Hala SM; Hamdan SM; Pain A; Alofi FS; Alsomali A; Hashem AM; Khogeer A; Almontashiri NAM; Abedalthagafi M; Hassan N; Mahfouz MM
    Virus Res; 2020 Oct; 288():198129. PubMed ID: 32822689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas-Integrated LAMP.
    Atçeken N; Yigci D; Ozdalgic B; Tasoglu S
    Biosensors (Basel); 2022 Nov; 12(11):. PubMed ID: 36421156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLEVER assay: A visual and rapid RNA extraction-free detection of SARS-CoV-2 based on CRISPR-Cas integrated RT-LAMP technology.
    Bhatt A; Fatima Z; Ruwali M; Misra CS; Rangu SS; Rath D; Rattan A; Hameed S
    J Appl Microbiol; 2022 Aug; 133(2):410-421. PubMed ID: 35396760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Field Detection Based on CRISPR/Cas System.
    Yuan M; Ding R; Chen S; Duan G
    ACS Synth Biol; 2021 Nov; 10(11):2824-2832. PubMed ID: 34714068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Detection of Influenza A and B Viruses by CRISPR-Cas12a-Based Assay.
    Park BJ; Park MS; Lee JM; Song YJ
    Biosensors (Basel); 2021 Mar; 11(3):. PubMed ID: 33808752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the use of the CRISPR-Cas system for the detection of infectious pathogens.
    Gao H; Shang Z; Chan SY; Ma D
    J Zhejiang Univ Sci B; 2022 Nov; 23(11):881-898. PubMed ID: 36379609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of CRISPR/Cas systems in the nucleic acid detection of pathogens: a review].
    Li M; Qin Z; Yin K; Zheng B
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Feb; 35(1):98-103. PubMed ID: 36974023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse Transcription-Loop-Mediated Isothermal Amplification-CRISPR-Cas13a Technology as a Promising Diagnostic Tool for SARS-CoV-2.
    Ortiz-Cartagena C; Fernández-García L; Blasco L; Pacios O; Bleriot I; López M; Cantón R; Tomás M
    Microbiol Spectr; 2022 Oct; 10(5):e0239822. PubMed ID: 36169448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.